Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Clever

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Blood|October 28, 2011
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effectDon M Benson, Courtney E Bakan, Shuhong Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
The Journal of Experimental Medicine|November 4, 2015
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor toleranceDouglas C Palmer, Geoffrey C Guittard, Zulmarie Franco, et al.
JCI Insight|December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapyChristopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Nature Immunology|May 10, 2016
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancersRahul Roychoudhuri, David Clever, Peng Li, et al.
Cancer Research|November 30, 2014
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristicsJoseph G Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, et al.
Cell Metabolism|December 18, 2015
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular TherapyMadhusudhanan Sukumar, Jie Liu, Gautam U Mehta, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Blood|October 28, 2011
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effectDon M Benson, Courtney E Bakan, Shuhong Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
The Journal of Experimental Medicine|November 4, 2015
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor toleranceDouglas C Palmer, Geoffrey C Guittard, Zulmarie Franco, et al.
JCI Insight|December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapyChristopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Nature Immunology|May 10, 2016
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancersRahul Roychoudhuri, David Clever, Peng Li, et al.
Cancer Research|November 30, 2014
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristicsJoseph G Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, et al.
Cell Metabolism|December 18, 2015
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular TherapyMadhusudhanan Sukumar, Jie Liu, Gautam U Mehta, et al.
Pageof 3